Paid Clinical Trials in New York

New York has 4,876 paid clinical trials enrolling now across cities including New York, The Bronx and Rochester. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in New York include Memorial Sloan Kettering, NYU Langone and Weill Cornell Medicine, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 14, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

4,285 clinical trials

Get a weekly email when new trials open in New York, NY.

Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation

for Paroxysmal Atrial Fibrillation (PAF)

Sites in New York +6 more locations

Sponsor: Boston Scientific Corporation

Sex: All·Age: 18+

Code: NCT07575269·Recruiting·Listed May 2026

Apply to this trial

NORM-HF Pivotal Study

for Heart Failure

Sites in New York +8 more locations

Sponsor: Foundry Innovation & Research 1, Limited (FIRE1)

Sex: All·Age: 18+

Code: NCT07574593·Recruiting·Listed May 2026

Apply to this trial

A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

for Hematologic Neoplasms

Sites in New York +5 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07572006·Phase 1·Recruiting·Listed May 2026

Apply to this trial

A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors

for Advanced NRAS-Mutant Melanoma

Sites in New York +8 more locations

Sponsor: Relay Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07584226·Phase 1·Recruiting·Listed May 2026

Apply to this trial

A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice

for Asthma

Sites in New York, New Windsor +54 more locations

Sponsor: Sanofi

Sex: All·Age: 6+

Code: NCT07556159·Recruiting·Listed Apr 2026

Apply to this trial

Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population

for CRC Screening

Sites in Carmel +4 more locations

Sponsor: Jubaan Ltd.

Sex: All·Age: 45 - 84

Code: NCT07623902·Recruiting·Listed Jun 2026

Apply to this trial

A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

for Non-small Cell Lung Cancer

Drug: Calderasib

Sites in Albany +1 more location

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT07554339·Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

Pornography Abstinence and Nocturnal Erections in Adult Men

for Erection

1 location in New York

Sponsor: Efforia, Inc

Sex: Male·Age: 18+·Accepts healthy volunteers

Code: NCT07618104·Recruiting·Listed Jun 2026

Apply to this trial

Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix

for Prostate Cancer Detection

Sites in Middletown +6 more locations

Sponsor: Sequenom, Inc.

Sex: Male·Age: 40 - 75

Code: NCT07543757·Recruiting·Listed Apr 2026

Apply to this trial

Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)

for Small Cell Lung Cancer

Drug: Tarlatamab

Sites in New York +6 more locations

Sponsor: Amgen

Sex: All·Age: 18 - 99

Code: NCT07531095·Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas

for HER2-negative

Drug: Nivolumab

Sites in New York, Albany +1 more location

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT07546812·Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

A Study of JNJ-1761981 in Participants With Solid Tumors

for Neoplasms

Sites in The Bronx +3 more locations

Sponsor: Johnson & Johnson Enterprise Innovation Inc.

Sex: All·Age: 18+

Code: NCT07525141·Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients

for High-Risk Neuroblastoma

Sites in The Bronx +4 more locations

Sponsor: Renaissance Pharma Ltd.

Sex: All·Age: 18 Months - 18

Code: NCT07549321·Phase 2, Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

for CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)

Sites in New York +5 more locations

Sponsor: Grifols Therapeutics LLC

Sex: All·Age: 18+

Code: NCT07540221·Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

Validation of Effectiveness on NaturalCycles Users

for Contraception

1 location in New York

Sponsor: Natural Cycles

Sex: Female·Age: 18 - 35

Code: NCT07566793·Recruiting·Listed May 2026

Apply to this trial

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

for Colorectal Cancer

Drug: Bevacizumab

Sites in Lake Success +3 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT07525206·Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension

for Hypertension

Sites in Staten Island +10 more locations

Sponsor: Kardigan, Inc.

Sex: All·Age: 18+

Code: NCT07511361·Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

The Short Sleep Study

for Short Sleepers

Sites in Garden City +3 more locations

Sponsor: Danisco

Sex: All·Age: 20 - 50

Code: NCT07567560·Recruiting·Listed May 2026

Apply to this trial

A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation

for Advanced/Metastatic Colorectal Adenocarcinoma

Drug: BAY 3771249

Sites in New York +6 more locations

Sponsor: Bayer

Sex: All·Age: 18+

Code: NCT07535112·Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

for Non-small Cell Lung Cancer

Sites in White Plains +11 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT07513376·Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

for Acute Promyelocytic Leukemia (APL)

Sites in The Bronx, Buffalo +12 more locations

Sponsor: Quetzal Therapeutics

Sex: All·Age: 18 - 71

Code: NCT07504458·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy

for Relapsed or Refractory Large B-cell Lymphoma

Sites in New York +13 more locations

Sponsor: Kite, A Gilead Company

Sex: All·Age: 18+

Code: NCT07479797·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder

for Muscle-invasive Bladder Cancer

Sites in New York +11 more locations

Sponsor: Astellas Pharma Global Development, Inc.

Sex: All·Age: 18+

Code: NCT07475806·Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

for Epidermal Growth Factor

Sites in Lake Success +5 more locations

Sponsor: EpiBiologics

Sex: All·Age: 18+

Code: NCT07462377·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

for Cardiovascular

Sites in Rochester +7 more locations

Sponsor: CRISPR Therapeutics AG

Sex: All·Age: 18 - 75

Code: NCT07491172·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers

for Venous Thromboembolism (VTE)

Sites in New York +2 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07493304·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)

for Erythropoietic Protoporphyria (EPP)

Sites in New York +4 more locations

Sponsor: Portal Therapeutics, Inc.

Sex: All·Age: 12+

Code: NCT07567131·Recruiting·Listed May 2026

Apply to this trial

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

for Neurological Disorder

Sites in New York, Buffalo +3 more locations

Sponsor: Synchron, Inc.

Sex: All·Age: 22+

Code: NCT07543367·Recruiting·Listed Apr 2026

Apply to this trial

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

for AML (Acute Myeloid Leukemia)

Sites in New York +1 more location

Sponsor: Rigel Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07486713·Phase 4·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

for Ocular Myasthenia Gravis

Sites in Amherst +4 more locations

Sponsor: UCB Biopharma SRL

Sex: All·Age: 18+

Code: NCT07463521·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

for Polycythemia Vera

Sites in The Bronx +7 more locations

Sponsor: Ono Pharmaceutical Co., Ltd.

Sex: All·Age: 18+

Code: NCT07429266·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

for Glioblastoma Multiforme of Brain

Sites in New York +2 more locations

Sponsor: Tetragon Biosciences Ltd

Sex: All·Age: 18+

Code: NCT07464925·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

for Primary Immune Thrombocytopenia (ITP)

Drug: Ianalumab

Sites in The Bronx +12 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07421167·Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

for Metastatic Castration-resistant Prostate Cancer

Sites in White Plains +15 more locations

Sponsor: BioNTech SE

Sex: Male·Age: 18+

Code: NCT07365995·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

A Study of GEN1106 in Participants With Solid Tumors

for Solid Tumors

Sites in Lake Success +4 more locations

Sponsor: Genmab

Sex: All·Age: 18+

Code: NCT07416123·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

for Pancreatic Ductal Adenocarcinoma (PDAC)

Sites in New York +5 more locations

Sponsor: BicycleTx Limited

Sex: All·Age: 18+

Code: NCT07450859·Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)

for T Cell Malignancies

Sites in New York +5 more locations

Sponsor: Electra Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT07465835·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

for Non Small Cell Lung Cancer (Squamous or Non Squamous)

Sites in New York, The Bronx +14 more locations

Sponsor: Eikon Therapeutics

Sex: All·Age: 18+

Code: NCT07365319·Phase 2, Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

A Phase 1 Study of the Safety and Tolerability of CTX-10726

for Gastroesophageal Cancer (GC)

Drug: CTX-10726

Sites in Lake Success +4 more locations

Sponsor: Compass Therapeutics

Sex: All·Age: 18+

Code: NCT07419841·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

for Bladder Cancer

Sites in New York +10 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT07419295·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial